drugset / Trial / NCT06944925

A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)

NCT06944925 ↗

Phase 1 Recruiting 286 enrolled Bambusa Therapeutics
RandomizedSequentialTriple-blindTreatment

Summary

Randomized study of single and multiple doses of BBT002 in healthy volunteers and in adult patients with chronic obstructive pulmonary disease (COPD) or chronic rhinosinusitis with nasal polyps (CRSwNP).

Timeline

Start
2025-05-08
Primary completion
2027-01-31
Completion
2027-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject BBT002 Unknown — Intravenous